Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Goldman Sachs just snapped up the $13 billion QQQI covered-call ETF, and its 14% yield looks irresistible until you see exactly what Nasdaq investors quietly surrendered to collect those monthly checks.
You found a great company, then watched it double before you got round to buying.
Qualcomm stock has clawed back from a post-earnings collapse and then some, but the recovery hides a complicated mix of shrinking handsets, unproven data center bets, and margin pressure that makes the next move anything but obvious.
The space company is making some exciting moves, but you may still want to think twice about investing in it right now.
Airbnb just posted its best single-session surge in years and climbed past every analyst target on the board, which puts shareholders in an uncomfortable spot where both trimming and buying carry real consequences.
Investors can take advantage of market volatility by buying these 3 stocks on the dip.
Best Buy (NYSE:BBY) delivered a quarter that turns skeptics into second-guessers. In its fiscal second-quarter results reported on August 27, comparable sales rose 4.1%, blowing past management’s own guidance of roughly 1%, and the company raised its full-year outlook across the board. The results arrived alongside a changing of the guard at the top, with […]
VYM promises high dividend yield, but a quiet rule buried in its index methodology carves out an entire income category that many retirees are counting on without realizing it is missing.
It's shocking that Reddit has underperformed this badly despite formidable fundamentals.
The company’s return to buying follows a summer downturn spent raising cash and selling Bitcoin.
History says you should buy the Micron stock pullback to a key trendline
By Stephen Culp and Niket Nishant NEW YORK, Aug 31 (Reuters) - U.S. stocks weakened on Monday with markets turning the page on a volatile month as a war-related price jump in crude revived inflation
AFRM's Q4 earnings beat is driven by 36% GMV growth, rising transactions and card adoption, while credit losses and expenses increase.
As Applied Materials has outperformed relative to the Dow over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Baird just handed two farm equipment stocks a rare double upgrade on the same morning, but the reasoning behind each call points to a very different bet on how the ag cycle turns.
Crypto stocks are surging midday even as Bitcoin and Ethereum trade lower, and one company's relentless weekly buying spree is now within striking distance of a milestone no crypto treasury has ever reached.
Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV. The approval marks the company’s second FDA-approved medicine this year, following the M
Sandisk’s massive Japan expansion could strengthen its supply position and give the company a bigger role in the AI data center boom.
Okta, CrowdStrike, Datadog, Cloudflare and Palo Alto Networks led Q2's most-upgraded stocks as AI-driven agentic traffic boosts cybersecurity demand, with analysts raising price targets and ratings.
IREN's co-CEO just made a bold claim about how the company funds its massive fiscal 2027 buildout without a big equity raise, and the market is reacting while peers like TeraWulf head in the opposite direction.
Dell Technologies (DELL) is set to report Q2 results after-market hours on Tuesday, Sept. 1, with expectations running high following explosive growth in its AI infrastructure business.
Snap-on has been treading water for the past six months, recording a small return of 0.6% while holding steady at $391.86. The stock also fell short of the S&P 500’s 12.3% gain during that period.
Palo Alto Networks Inc (NYSE:PANW, XETRA:5AP) is likely to top fiscal fourth-quarter expectations on remaining performance obligations, annual recurring revenue and total revenue, with product growth potentially reaching 18% year-over-year versus consensus, according to Jefferies. Shares have...
IDEX trades at $230.28 and has moved in lockstep with the market. Its shares have returned 8.9% over the last six months while the S&P 500 has gained 12.3%.
Vanguard's S&P 500 ETF is still a solid long-term investment.
JFrog, CMB.Tech and Frontline are near buy points as their relative performance vs. other stocks hit new highs.
Can SOUN's rising healthcare deals, customer spending and faster OASYS deployments turn healthcare into its next major growth engine?
Higher crude supports upstream profit, while Washington's gasoline scrutiny threatens how much refining margin reaches shareholders.
Science Applications International (SAIC) raised its fiscal 2027 outlook on Monday as its second-qua
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.